Cargando…
Function of BRD4 in the pathogenesis of high glucose-induced cardiac hypertrophy
Diabetic cardiomyopathy is one of the major complications of diabetes, and due to the increasing number of patients with diabetes it is a growing concern. Diabetes-induced cardiomyopathy has a complex pathogenesis and histone deacetylase-mediated epigenetic processes are of prominent importance. The...
Autores principales: | Wang, Qian, Sun, Yuxin, Li, Tianshu, Liu, Lianqin, Zhao, Yunxia, Li, Liyuan, Zhang, Ling, Meng, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297744/ https://www.ncbi.nlm.nih.gov/pubmed/30483785 http://dx.doi.org/10.3892/mmr.2018.9681 |
Ejemplares similares
-
The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy
por: Li, Zhenzhen, et al.
Publicado: (2021) -
Bellidifolin ameliorates isoprenaline-induced cardiac hypertrophy by the Nox4/ROS signalling pathway through inhibiting BRD4
por: Zhou, Dingyan, et al.
Publicado: (2023) -
The Microenvironment of the Pathogenesis of Cardiac Hypertrophy
por: Bazgir, Farhad, et al.
Publicado: (2023) -
The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis
por: Drumond-Bock, Ana Luiza, et al.
Publicado: (2021) -
BRD4 Silencing Protects Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting TLR4/NF-κB and Activating Nrf2-HO-1 Pathways
por: Fang, Ming, et al.
Publicado: (2022)